Skip to main content
Signal8

Horn Howard

SEC insider (Form 3/4/5 filer). CIK 0001786335. Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE). 18 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in NOVATO, CA.

Companies Horn Howard has filed insider reports for

  • Ultragenyx Pharmaceutical Inc. (RARE): Officer, Chief Financial Officer
Horn Howard profile photo

Horn Howard

CIK: 0001786335

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ultragenyx Pharmaceutical Inc. logo
RARE

Ultragenyx Pharmaceutical Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Oct 15, 2026
    Sale
    Direct
    7.1K shares at avg. $15.27$108K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Aug 3, 2026
    Sale
    Direct
    4.7K shares at avg. $24.92$117K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Jul 1, 2026
    Sale
    Direct
    4.7K shares at avg. $33.13$156K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Jun 1, 2026
    Sale
    Direct
    4.7K shares at avg. $23.77$111K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    May 1, 2026
    Sale
    Direct
    4.7K shares at avg. $24.90$117K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Apr 16, 2026
    Award
    Direct
    34.7K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Apr 1, 2026
    Sale
    Direct
    4.7K shares at avg. $20.97$98K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 3, 2026
    Sale
    Direct
    1.6K shares at avg. $22.40$37K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 2, 2026
    Sale
    Direct
    3.1K shares at avg. $22.54$70K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 2, 2026
    Sale
    Direct
    5.3K shares at avg. $22.80$121K

1-10 of 18